Clinical Trial Update: Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers [NA]

View source ↗

Summary

The clinical trial investigating nasopharyngeal 24-hour pH monitoring in healthy adult volunteers for gastroesophageal reflux disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: University of California, Davis | Conditions: Gastroesophageal Reflux Disease | NA | Status: WITHDRAWN